Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $519.97 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $303.31 | 21 | $0 (2023) |
| ABBVIE INC. | $70.21 | 3 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $34.29 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $32.96 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $29.99 | 2 | $0 (2022) |
| Mylan Specialty L.P. | $19.91 | 1 | $0 (2021) |
| Abbott Laboratories | $15.25 | 1 | $0 (2022) |
| Lilly USA, LLC | $14.05 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32.96 | 2 | AstraZeneca Pharmaceuticals LP ($32.96) |
| 2023 | $213.22 | 14 | GlaxoSmithKline, LLC. ($164.88) |
| 2022 | $237.64 | 15 | GlaxoSmithKline, LLC. ($138.43) |
| 2021 | $36.15 | 2 | Mylan Specialty L.P. ($19.91) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Respiratory | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Respiratory | ||||||
| 12/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $14.58 | General |
| 11/29/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.81 | General |
| Category: RESPIRATORY | ||||||
| 09/14/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.02 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.65 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Diabetes | ||||||
| 05/23/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.75 | General |
| Category: RESPIRATORY | ||||||
| 03/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.57 | General |
| Category: RESPIRATORY | ||||||
| 02/14/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV | Food and Beverage | In-kind items and services | $19.71 | General |
| 01/17/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.69 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.37 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.31 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug), STEGLUJAN, STEGLATRO | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/23/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.63 | General |
| Category: RESPIRATORY | ||||||
| 08/11/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: GLAUCOMA | ||||||
| 07/20/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: GLAUCOMA | ||||||
| 06/15/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: GLAUCOMA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 42 | 65 | $5,850 | $1,672 |
| 2022 | 2 | 27 | 35 | $2,955 | $996.78 |
| 2021 | 1 | 57 | 172 | $12,900 | $4,242 |
| 2020 | 1 | 105 | 446 | $33,450 | $11,405 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 22 | 44 | $3,960 | $1,024 | 25.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 20 | 21 | $1,890 | $648.47 | 34.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 14 | 16 | $1,365 | $521.95 | 38.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 13 | 19 | $1,590 | $474.83 | 29.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 57 | 172 | $12,900 | $4,242 | 32.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 105 | 446 | $33,450 | $11,405 | 34.1% |
About Jason Bowen, FNP
Jason Bowen, FNP is a Nurse Practitioner healthcare provider based in Mendenhall, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2012. The National Provider Identifier (NPI) number assigned to this provider is 1306182035.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jason Bowen, FNP has received a total of $519.97 in payments from pharmaceutical and medical device companies, with $32.96 received in 2024. These payments were reported across 33 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($519.97).
As a Medicare-enrolled provider, Bowen has provided services to 231 Medicare beneficiaries, totaling 718 services with total Medicare billing of $18,316. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Mendenhall, MS
- Active Since 12/28/2012
- Last Updated 12/28/2012
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306182035
Products in Payments
- TRELEGY ELLIPTA (Drug) $178.31
- AREXVY (Drug) $125.00
- DURYSTA (Drug) $70.21
- BREZTRI (Drug) $32.96
- VERQUVO (Drug) $29.99
- Yupelri (Drug) $19.91
- FREESTYLE LIBRE 2 (Device) $15.25
- MOUNJARO (Drug) $14.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.